Valeant Pharmaceuticals reported $1.06B in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Amgen AMGN:US USD 4.93B 173M
Ani Pharmaceuticals ANIP:US USD 95.89M 3.35M
Aurora Cannabis Inc ACB:CN CAD 146.24M 6.32M
Biogen BIIB:US USD 1.38B 80.8M
Canopy Growth Corp WEED:CN CAD 211.21M 5.7M
Catalent CTLT:US USD 753M 29M
Corcept Therapeutics CORT:US USD 17.07M 342K
Danaher DHR:US USD 3.11B 126M
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Gilead Sciences GILD:US USD 2.82B 218M
Horizon Pharma HZNP:US USD 190.26M 13.42M
JAZZ PHA JAZZ:US USD 728.07M 133.63M
Lannett LCI:US USD 94.78M 658K
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Pacira Pharmaceuticals PCRX:US USD 96.8M 3.79M
Perrigo Ordinary Shares PRGO:US USD 1.09B 5.6M
Phibro Animal Health PAHC:US USD 280.84M 21.68M
Prestige Brands PBH:US USD 158.52M 18.02M
Revance Therapeutics RVNC:US USD 17.18M 3.58M
Supernus Pharmaceuticals SUPN:US USD 83.16M 1.69M
Valeant Pharmaceuticals VRX:CN USD 1.06B 17M
Vertex Pharmaceuticals VRTX:US USD 388.2M 20.5M
Zoetis ZTS:US USD 2.3B 98M